• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Different treatment choice for first-line treatment of Helicobacter pylori in an area with a high antibiotic resistance.

作者信息

Başyiğit Sebahat, Kefeli Ayşe, Yeniova Abdullah Özgür, Uzman Metin, Nazlıgül Yaşar, Aktaş Bora

机构信息

Department of Gastroenterology, Ankara Keçiören Research and Education Hospital, Ankara, Turkey.

出版信息

Turk J Gastroenterol. 2014 Dec;25 Suppl 1:293-4. doi: 10.5152/tjg.2014.6085.

DOI:10.5152/tjg.2014.6085
PMID:25910347
Abstract
摘要

相似文献

1
Different treatment choice for first-line treatment of Helicobacter pylori in an area with a high antibiotic resistance.
Turk J Gastroenterol. 2014 Dec;25 Suppl 1:293-4. doi: 10.5152/tjg.2014.6085.
2
[Acid-related diseases. What is the current rescue treatment of choice for Helicobacter pylori: quadruple therapy (proton pump inhibitor, bismuth, tetracycline and metronidazole) or triple therapy with proton pump inhibitor, amoxicillin and levofloxacin?].[酸相关性疾病。幽门螺杆菌目前的首选挽救治疗方案是什么：四联疗法（质子泵抑制剂、铋剂、四环素和甲硝唑）还是质子泵抑制剂、阿莫西林和左氧氟沙星的三联疗法？]
Gastroenterol Hepatol. 2008 Jun-Jul;31(6):400-1. doi: 10.1157/13123612.
3
Multiple-antibiotic-resistant Helicobacter pylori infection eradicated with a tailor-made quadruple therapy.经个体化定制的四联疗法根除多重抗生素耐药性幽门螺杆菌感染。
J Gastroenterol Hepatol. 2012 Apr;27 Suppl 3:108-11. doi: 10.1111/j.1440-1746.2012.07069.x.
4
Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance.
Am J Gastroenterol. 1998 Jan;93(1):2-3. doi: 10.1111/j.1572-0241.1998.002_c.x.
5
[PPI plus bismuth-based quintuple therapy].
Nihon Rinsho. 2005 Nov;63 Suppl 11:452-8.
6
Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.基于枸橼酸铋雷尼替丁的三联疗法治疗幽门螺杆菌的随机对照比较
Am J Gastroenterol. 1997 Dec;92(12):2213-5.
7
High-dose rabeprazole-amoxicillin dual therapy and rabeprazole triple therapy with amoxicillin and levofloxacin for 2 weeks as first and second line rescue therapies for Helicobacter pylori treatment failures.高剂量雷贝拉唑-阿莫西林双联疗法和雷贝拉唑三联疗法（阿莫西林和左氧氟沙星）作为治疗幽门螺杆菌治疗失败的一线和二线挽救疗法，疗程均为 2 周。
Aliment Pharmacol Ther. 2012 May;35(9):1097-102. doi: 10.1111/j.1365-2036.2012.05054.x. Epub 2012 Mar 8.
8
Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study.两周序贯与同时疗法根除幽门螺杆菌的临床疗效：一项随机初步研究。
Helicobacter. 2013 Jun;18(3):180-6. doi: 10.1111/hel.12034. Epub 2013 Jan 11.
9
Comparison of Helicobacter pylori eradication rates of standard 14-day quadruple treatment and novel modified 10-day, 12-day and 14-day sequential treatments.标准14天四联疗法与新型改良10天、12天和14天序贯疗法根除幽门螺杆菌率的比较
Eur J Intern Med. 2014 Mar;25(3):224-9. doi: 10.1016/j.ejim.2013.11.006. Epub 2013 Nov 20.
10
The effect of intragastric acidity on Helicobacter pylori eradication with bismuth-metronidazole-amoxicillin.胃内酸度对铋剂-甲硝唑-阿莫西林根除幽门螺杆菌的影响。
Hepatogastroenterology. 1999 Jul-Aug;46(28):2713-7.

引用本文的文献

1
Chinese Helicobacter pylori vaccine: Solution for an old challenge?中国幽门螺杆菌疫苗：应对一项旧挑战的解决方案？
World J Gastrointest Pharmacol Ther. 2016 Aug 6;7(3):412-5. doi: 10.4292/wjgpt.v7.i3.412.